Table 2.
Summary of neoadjuvant chemoradiotherapy n (%)
| Neoadjuvant chemoradiotherapy (n = 12) | |
| Regimen of chemotherapy | |
| 5-fluorouracil + leucovorin | 5 (41.7) |
| Gemcitabine | 5 (41.7) |
| Gemcitabine + cisplatin | 1 (8.3) |
| Tegfur/Uracil (UFT) | 1 (8.3) |
| Total dose of radiotherapy (cGy) | 5040 (4545, 5040)1 |
| Response in follow-up image | |
| Partial response | 7 (58.3) |
| Stable disease | 5 (41.7) |
| Complete response in pathology | 2 (16.7) |
| Downstaging of TNM stage | 4 (33.3) |
| Toxicity | |
| ≥ Grade II | 2 (16.7) |
1Continuous variables were denoted median (Q1, Q3) and categorical variables were denoted number (%).